Torrent Pharma ropes in Manish Kainth as CHRO
Ahmedabad: Torrent Pharma has appointed Manish Kainth as its Chief Human Resources Officer (CHRO).
Before joining Torrent, Kainth spent over a decade at Tata Consumer Products, where he held several senior leadership roles including Senior Vice President-HR, Head of HR for International Business, and Vice President-HR.
Prior to Tata Consumer Products, he was General Manager-Human Resources at GlaxoSmithKline Consumer Healthcare. Kainth’s earlier career includes positions at Tata Motors, Hindustan Unilever, IBM, and HSBC, reflecting broad experience across industries.
In related news, Medical Dialogues team in May reported the appointment of Aman Mehta, the third generation of Torrent Group's founder Mehta family, as Managing Director and Whole-time Key Managerial Personnel of the Company for the period of 5 years.
Read also: Third-Gen Leadership: Aman Mehta set to lead Torrent Pharma as MD
Also in May, the company received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase III clinical trial of the antidiabetic drug Semaglutide Tablets 3mg, 7 mg, and 14 mg (synthetic origin). Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults.
Read also: Torrent Pharmaceutical Gets CDSCO Panel Nod To study Semaglutide Tablets
Torrent Pharmaceuticals, headquartered in Ahmedabad, Gujarat, is a prominent Indian pharmaceutical company known for developing, manufacturing, and marketing branded and generic medications. It operates across various therapeutic areas, including cardiovascular, central nervous system, and diabetes care, with a strong presence in both regulated and emerging global markets.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.